James Marroquin, MD
@jamesmarroquin.bsky.social
Internist, Assistant Professor of Medical Education at UT Dell Medical School, Austin, TX
Reposted by James Marroquin, MD
Everything that is wrong with this administration (and many in our society) is encapsulated in the firing of the commissioner of labor statistics
The eschewing of expertise
Rather than changing course in response to data, questioning the data
Ideology over reality
The eschewing of expertise
Rather than changing course in response to data, questioning the data
Ideology over reality
August 3, 2025 at 12:47 PM
Everything that is wrong with this administration (and many in our society) is encapsulated in the firing of the commissioner of labor statistics
The eschewing of expertise
Rather than changing course in response to data, questioning the data
Ideology over reality
The eschewing of expertise
Rather than changing course in response to data, questioning the data
Ideology over reality
Reposted by James Marroquin, MD
Big find: Vaccines with AS01 adjuvant (shingles, RSV) tied to less dementia. The immune system might be fighting more than infections. www.nature.com/articles/s41...
#BlueSky #MedSky #NewsSky #SciSky 🧪 #NurseSky #IDSky #EMSky
#PedsSky #NeuroSky
#BlueSky #MedSky #NewsSky #SciSky 🧪 #NurseSky #IDSky #EMSky
#PedsSky #NeuroSky
Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections - npj Vaccines
npj Vaccines - Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections
www.nature.com
June 27, 2025 at 10:10 PM
RSV Vaccine Tied to Lower Dementia Risk www.medpagetoday.com/neurology/de...
RSV Vaccine Tied to Lower Dementia Risk
Arexy's AS01 adjuvant may play a role
www.medpagetoday.com
June 27, 2025 at 4:12 PM
RSV Vaccine Tied to Lower Dementia Risk www.medpagetoday.com/neurology/de...
Access Doesn’t Guarantee Value
open.substack.com/pub/33charts...
open.substack.com/pub/33charts...
Access Doesn’t Guarantee Value
Our obsession with inputs is breaking our ability to care
open.substack.com
June 18, 2025 at 1:27 AM
Access Doesn’t Guarantee Value
open.substack.com/pub/33charts...
open.substack.com/pub/33charts...
I’m Stepping Away. Can You Cover for Me?—Supporting Faith-Based Practices url:https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2835430?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=061725
June 18, 2025 at 1:20 AM
I’m Stepping Away. Can You Cover for Me?—Supporting Faith-Based Practices url:https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2835430?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=061725
This Common, Safe Drug Relieved Osteoarthritis Pain in Randomized Trial www.medpagetoday.com/rheumatology...
This Common, Safe Drug Relieved Osteoarthritis Pain in Randomized Trial
Many OA patients probably have it in the cabinet already -- and it's not an NSAID
www.medpagetoday.com
June 15, 2025 at 1:11 PM
This Common, Safe Drug Relieved Osteoarthritis Pain in Randomized Trial www.medpagetoday.com/rheumatology...
Will the FDA approve the first new drug to help people quit smoking in 20 years? www.statnews.com/2025/04/30/n... via @statnews.com
Will the FDA approve the first new drug to help people quit smoking in 20 years?
The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new smoking cessation medication in two decades.
www.statnews.com
June 15, 2025 at 1:10 PM
Will the FDA approve the first new drug to help people quit smoking in 20 years? www.statnews.com/2025/04/30/n... via @statnews.com
Nerandomilast for Idiopathic Pulmonary Fibrosis | New England Journal of Medicine www.nejm.org/do/10.1056/N...
Nerandomilast for Idiopathic Pulmonary Fibrosis | NEJM
Quick Take Video Summary from The New England Journal of Medicine — Nerandomilast for Idiopathic Pulmonary Fibrosis
www.nejm.org
June 15, 2025 at 12:57 PM
Nerandomilast for Idiopathic Pulmonary Fibrosis | New England Journal of Medicine www.nejm.org/do/10.1056/N...
Finerenone for Heart Failure and Risk Estimated by the PREDICT-HFpEF Model url:https://jamanetwork.com/journals/jamacardiology/fullarticle/2830951?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=061525
June 15, 2025 at 12:55 PM
Finerenone for Heart Failure and Risk Estimated by the PREDICT-HFpEF Model url:https://jamanetwork.com/journals/jamacardiology/fullarticle/2830951?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=061525
Cuffless Blood Pressure Measurement Devices url:https://jamanetwork.com/journals/jamacardiology/fullarticle/2832857?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=061525
June 15, 2025 at 12:52 PM
Cuffless Blood Pressure Measurement Devices url:https://jamanetwork.com/journals/jamacardiology/fullarticle/2832857?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=061525
First Blood Test for Alzheimer Biomarkers Receives FDA Clearance url:https://jamanetwork.com/journals/jama/fullarticle/2835490?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=061525
June 15, 2025 at 12:42 PM
First Blood Test for Alzheimer Biomarkers Receives FDA Clearance url:https://jamanetwork.com/journals/jama/fullarticle/2835490?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=061525
AI Tool Sharpens Parkinsonism Diagnoses url:https://jamanetwork.com/journals/jama/fullarticle/2835491?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=061525
June 15, 2025 at 12:40 PM
AI Tool Sharpens Parkinsonism Diagnoses url:https://jamanetwork.com/journals/jama/fullarticle/2835491?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=061525
“Jung’s ideas about happiness and his five pillars of well-being stand up solidly to modern research findings,” writes @arthurbrooks:
June 15, 2025 at 12:09 PM
“Jung’s ideas about happiness and his five pillars of well-being stand up solidly to modern research findings,” writes @arthurbrooks:
Reposted by James Marroquin, MD
RFK Jr. and other anti-vaxxers often lie and claim that there have not been RCTs done on vaccines. Here's links showing that they are wrong:
#Medsky
www.bradspellberg.com/vaccine-rcts
#Medsky
www.bradspellberg.com/vaccine-rcts
Vaccine RCTs | mysite
www.bradspellberg.com
May 30, 2025 at 2:47 PM
RFK Jr. and other anti-vaxxers often lie and claim that there have not been RCTs done on vaccines. Here's links showing that they are wrong:
#Medsky
www.bradspellberg.com/vaccine-rcts
#Medsky
www.bradspellberg.com/vaccine-rcts
Decade after decade Medicare and insurance pays one of the most challenging specialties the least amount of $. Of course PCPs are moving to alternative care models.
Primary Care — From Common Good to Free-Market Commodity | New England Journal of Medicine www.nejm.org/doi/full/10....
Primary Care — From Common Good to Free-Market Commodity | New England Journal of Medicine www.nejm.org/doi/full/10....
Primary Care — From Common Good to Free-Market Commodity | NEJM
Primary care physicians have been leaving traditional practices for concierge and
direct primary care practices, in which patients are offered personalized and more
accessible primary care in excha...
www.nejm.org
May 24, 2025 at 12:15 PM
Decade after decade Medicare and insurance pays one of the most challenging specialties the least amount of $. Of course PCPs are moving to alternative care models.
Primary Care — From Common Good to Free-Market Commodity | New England Journal of Medicine www.nejm.org/doi/full/10....
Primary Care — From Common Good to Free-Market Commodity | New England Journal of Medicine www.nejm.org/doi/full/10....
Reposted by James Marroquin, MD
Semaglutide significantly improved liver health and reduced body weight in patients with metabolic dysfunction-associated steatohepatitis.
by Sanyal AJ, Newsome PN (...) Ratziu V et 8 al. in N Engl J Med #MedSky
👉 get more here
📖 read the article: https://www.nejm.org/doi/10.1056/NEJMoa2413258
by Sanyal AJ, Newsome PN (...) Ratziu V et 8 al. in N Engl J Med #MedSky
👉 get more here
📖 read the article: https://www.nejm.org/doi/10.1056/NEJMoa2413258
May 9, 2025 at 8:32 PM
Semaglutide significantly improved liver health and reduced body weight in patients with metabolic dysfunction-associated steatohepatitis.
by Sanyal AJ, Newsome PN (...) Ratziu V et 8 al. in N Engl J Med #MedSky
👉 get more here
📖 read the article: https://www.nejm.org/doi/10.1056/NEJMoa2413258
by Sanyal AJ, Newsome PN (...) Ratziu V et 8 al. in N Engl J Med #MedSky
👉 get more here
📖 read the article: https://www.nejm.org/doi/10.1056/NEJMoa2413258
RSV sent fewer babies to the hospital last winter, after new treatment and vaccine arrived www.statnews.com/2025/05/08/c... via @statnews.com
RSV sent fewer babies to the hospital last winter, after new treatment and vaccine arrived
Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became widely available.
www.statnews.com
May 8, 2025 at 8:30 PM
RSV sent fewer babies to the hospital last winter, after new treatment and vaccine arrived www.statnews.com/2025/05/08/c... via @statnews.com
Reposted by James Marroquin, MD
Lepodisiran is a long-acting small interfering RNA that blocks hepatic apolipoprotein(a) production. A new Quick Take video covers the ALPACA trial’s findings in patients with elevated lipoprotein(a).
🎥 Watch now: youtu.be/B0aH0O9Pk7Q
#MedSky #CardioSky
🎥 Watch now: youtu.be/B0aH0O9Pk7Q
#MedSky #CardioSky
Lepodisiran: an RNA Targeting Lipoprotein(a) (ALPACA trial) | NEJM
YouTube video by NEJM Group
youtu.be
May 3, 2025 at 7:02 PM
Lepodisiran is a long-acting small interfering RNA that blocks hepatic apolipoprotein(a) production. A new Quick Take video covers the ALPACA trial’s findings in patients with elevated lipoprotein(a).
🎥 Watch now: youtu.be/B0aH0O9Pk7Q
#MedSky #CardioSky
🎥 Watch now: youtu.be/B0aH0O9Pk7Q
#MedSky #CardioSky
Death by a Thousand Cuts — The Crushing Weight of Nonclinical Demands in Primary Care | New England Journal of Medicine www.nejm.org/doi/full/10....
Death by a Thousand Cuts — The Crushing Weight of Nonclinical Demands in Primary Care | NEJM
Inadequate payment is just one of many factors that negatively affect daily practice
and contribute to burnout among primary care physicians. Also problematic are growing
piles of nonclinical tasks.
www.nejm.org
May 3, 2025 at 6:47 PM
Death by a Thousand Cuts — The Crushing Weight of Nonclinical Demands in Primary Care | New England Journal of Medicine www.nejm.org/doi/full/10....
Reposted by James Marroquin, MD
HUGE NEWS.
A study presented at #AACR25 found that one dose of the HPV vaccine (which prevents CANCER) is as effective as two, with efficacy rates >97%.
A study presented at #AACR25 found that one dose of the HPV vaccine (which prevents CANCER) is as effective as two, with efficacy rates >97%.
May 2, 2025 at 4:24 PM
HUGE NEWS.
A study presented at #AACR25 found that one dose of the HPV vaccine (which prevents CANCER) is as effective as two, with efficacy rates >97%.
A study presented at #AACR25 found that one dose of the HPV vaccine (which prevents CANCER) is as effective as two, with efficacy rates >97%.
